Home > Healthcare > Medical Devices > Diagnostic Devices > U.S. Biological Sample Collection Kits Market

U.S. Biological Sample Collection Kits Market Size

  • Report ID: GMI10495
  • Published Date: Jul 2024
  • Report Format: PDF

A PHP Error was encountered

Severity: Warning

Message: getimagesize(.S. Biological Sample Collection Kits Market Size</h2> <p>U.S. Biological Sample Collection Kits Market size was valued at USD 2.5 billion in 2023 and is expected to exhibit growth at a CAGR of 7.8% from 2024 to 2032. The rising usage of laboratory tests for precise disease diagnosis is a key factor driving the demand for the market.<br width=): failed to open stream: No such file or directory

Filename: v2_reports/body1.php

Line Number: 435

Backtrace:

File: /home/admin/web/gminsights.com/public_html/application/views/v2_reports/body1.php
Line: 435
Function: getimagesize

File: /home/admin/web/gminsights.com/public_html/application/views/v2_layouts/master_header_footer.php
Line: 1251
Function: view

File: /home/admin/web/gminsights.com/public_html/application/controllers/Reports.php
Line: 703
Function: view

File: /home/admin/web/gminsights.com/public_html/index.php
Line: 305
Function: require_once

U.S. Biological Sample Collection Kits Market Size

U.S. Biological Sample Collection Kits Market size was valued at USD 2.5 billion in 2023 and is expected to exhibit growth at a CAGR of 7.8% from 2024 to 2032. The rising usage of laboratory tests for precise disease diagnosis is a key factor driving the demand for the market.

 

U.S. Biological Sample Collection Kits Market

With the increasing emphasis on early and accurate diagnosis, there is a growing reliance on advanced diagnostic tests that require high-quality biological samples. For instance, according to the American Clinical Laboratory Association (ACLA), approximately 13 billion laboratory tests are performed annually in the U.S., underscoring the critical role of lab testing in healthcare. The need for accurate and early diagnosis, particularly in the fields of personalized medicine, infectious disease testing, and chronic disease management, underscores the importance of reliable sample collection. With the market for clinical laboratory services expected to continue growing, the demand for high-quality biological sample collection kits is likely to remain robust.
 

Biological sample collection kits are specialized packages or containers designed to safely and efficiently collect, preserve, and transport various types of biological specimens for laboratory analysis. These kits are crucial in biomedical and clinical research, diagnostics, and healthcare settings where accurate and reliable analysis of biological samples is essential.

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

U.S. biological sample collection kits industry was valued at USD 2.5 billion in 2023 and is expected to exhibit 7.8% CAGR from 2024 to 2032 due to rising usage of laboratory tests for precise disease diagnosis

The swabs product segment generated USD 695.2 million in 2023 as they are essential for collecting samples to diagnose various infectious diseases beyond COVID-19

U.S. biological sample collection kits market from the hospitals and clinics end-use segment is expected to grow at 7.6% CAGR between 2024 and 2032 as they perform a broad spectrum of diagnostic testing, including blood testing, urine testing, swab testing, and tissue biopsies

Abbott Laboratories, Becton, Dickinson and Company, CTK Biotech, Inc., F. Hoffmann-La Roche Ltd, Hardy Diagnostics, Laboratory Corporation of America Holdings, Lucence Health Inc., and Medline Industries, Inc.

U.S. Biological Sample Collection Kits Market Scope

Buy Now


Premium Report Details

  • Base Year: 2023
  • Companies covered: 11
  • Tables & Figures: 20
  • Countries covered: 1
  • Pages: 75
 Download Free Sample